ACLX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ACLX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-12-16), Arcellx's share price is $83.80. Arcellx does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.
The historical rank and industry rank for Arcellx's Price-to-Owner-Earnings or its related term are showing as below:
As of today (2024-12-16), Arcellx's share price is $83.80. Arcellx's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.71. Therefore, Arcellx's PE Ratio (TTM) for today is At Loss.
As of today (2024-12-16), Arcellx's share price is $83.80. Arcellx's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.71. Therefore, Arcellx's PE Ratio without NRI for today is At Loss.
The historical data trend for Arcellx's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcellx Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Price-to-Owner-Earnings | - | - | - | - | - |
Arcellx Quarterly Data | ||||||||||||||||||
Dec19 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Price-to-Owner-Earnings | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, Arcellx's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Arcellx's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Arcellx's Price-to-Owner-Earnings falls into.
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Arcellx's Price-to-Owner-Earnings for today is calculated as
Price-to-Owner-Earnings | = | Share Price | / | Owner Earnings per Share (TTM) |
= | 83.80 | / | 0.00 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcellx (NAS:ACLX) Price-to-Owner-Earnings Explanation
For how to get Owner Earnings per Share (TTM), please click.
Thank you for viewing the detailed overview of Arcellx's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.
Kavita Patel | director | C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451 |
Michelle Gilson | officer: Chief Financial Officer | 25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG MD 20878 |
Christopher Heery | officer: Chief Medical Officer | C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW STREET, SUITE A-100, DURHAM NC 27701 |
Olivia C Ware | director | 11726 SAN VICENTE BLVD, SUITE 650, LOS ANGELES CA 90049 |
Rami Elghandour | director, officer: See Remarks | 15 BARCELONA CIR, REDWOOD CITY CA 94065 |
Jill Carroll | director | C/O APPLIED GENETIC TECHNOLOGIES CORP., 11801 RESEARCH DRIVE, SUITE D, ALACHUA FL 32615 |
Sr One Capital Fund I Aggregator Lp | 10 percent owner | C/O DESIGN THERAPEUTICS, INC., 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD CA 92011 |
Scott D Sandell | 10 percent owner | |
Forest Baskett | 10 percent owner | |
Mohamad Makhzoumi | 10 percent owner | 2855 SAND HILL ROAD, MENLO PARK CA 94025 |
Florence Anthony A. Jr. | 10 percent owner | 5425 WISCONSIN AVENUE, SUITE 800, CHEVY CHASE MD 20815 |
New Enterprise Associates 15, L.p. | 10 percent owner | 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
Sr One Capital Management, Llc | 10 percent owner | 985 OLD EAGLE SCHOOL ROAD, SUITE 511, WAYNE PA 19087 |
Sr One Co-invest Ii Manager, Llc | 10 percent owner | 985 OLD EAGLE SCHOOL ROAD, SUITE 511, WAYNE PA 19087 |
Novo Holdings A/s | 10 percent owner | TUBORG HAVNEVEJ 19, HELLERUP G7 2900 |
From GuruFocus
By Marketwired • 07-19-2023
By PRNewswire • 11-15-2023
By GuruFocus Research • 02-13-2024
By GuruFocus News • 11-15-2024
By GuruFocus Research • 06-29-2024
By GuruFocus News • 11-13-2024
By Business Wire • 05-09-2024
By PRNewswire • 07-17-2023
By PRNewswire • 08-14-2023
By PRNewswire • 10-26-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.